
Galvanize Therapeutics Deploys Aliya EX System for First Patient Procedures
Redwood City-based Galvanize Therapeutics has successfully completed the first commercial procedures using its Aliya EX system, a pulsed electric field platform designed for soft tissue ablation. The milestone, occurring months after May 2026 FDA clearance, marks the system's debut in both percutaneous and endoscopic clinical settings across the United States.
























